Description
Composition- Sitagliptin 50 mg + Metformin 1000 mg
Mode of Action- Provides dual-pathway glycemic control through incretin support and reduced hepatic glucose production with improved insulin sensitivity.
USPs- Effective dual therapy option; useful in individualized diabetes management; dependable glucose-lowering support.
Prescribing Specialties- Diabetologist, General Physician
